122 related articles for article (PubMed ID: 24618431)
1. Pharmacogenomics update in pancreatic cancer.
Puri A; Saif MW
JOP; 2014 Mar; 15(2):114-7. PubMed ID: 24618431
[TBL] [Abstract][Full Text] [Related]
2. [Genetic aspects of pancreatic cancer].
Grigor'eva IN; Efimova OV; Suvorova TS; Tov NL
Eksp Klin Gastroenterol; 2014; (10):70-6. PubMed ID: 25911935
[TBL] [Abstract][Full Text] [Related]
3. Genetic alterations of K-ras, p53, c-erbB-2, and DPC4 in pancreatic ductal adenocarcinoma and their correlation with patient survival.
Shin SH; Kim SC; Hong SM; Kim YH; Song KB; Park KM; Lee YJ
Pancreas; 2013 Mar; 42(2):216-22. PubMed ID: 23344532
[TBL] [Abstract][Full Text] [Related]
4. Immortalizing the complexity of cancer metastasis: genetic features of lethal metastatic pancreatic cancer obtained from rapid autopsy.
Embuscado EE; Laheru D; Ricci F; Yun KJ; de Boom Witzel S; Seigel A; Flickinger K; Hidalgo M; Bova GS; Iacobuzio-Donahue CA
Cancer Biol Ther; 2005 May; 4(5):548-54. PubMed ID: 15846069
[TBL] [Abstract][Full Text] [Related]
5. Genetic and epigenetic alterations of familial pancreatic cancers.
Brune K; Hong SM; Li A; Yachida S; Abe T; Griffith M; Yang D; Omura N; Eshleman J; Canto M; Schulick R; Klein AP; Hruban RH; Iacobuzio-Donohue C; Goggins M
Cancer Epidemiol Biomarkers Prev; 2008 Dec; 17(12):3536-42. PubMed ID: 19064568
[TBL] [Abstract][Full Text] [Related]
6. Utility of Assessing the Number of Mutated KRAS, CDKN2A, TP53, and SMAD4 Genes Using a Targeted Deep Sequencing Assay as a Prognostic Biomarker for Pancreatic Cancer.
Hayashi H; Kohno T; Ueno H; Hiraoka N; Kondo S; Saito M; Shimada Y; Ichikawa H; Kato M; Shibata T; Morizane C; Sakamoto Y; Shimada K; Komatsu Y; Sakamoto N; Okusaka T
Pancreas; 2017 Mar; 46(3):335-340. PubMed ID: 28099251
[TBL] [Abstract][Full Text] [Related]
7. KRAS in pancreatic cancer.
Agarwal A; Saif MW
JOP; 2014 Jul; 15(4):303-5. PubMed ID: 25076326
[TBL] [Abstract][Full Text] [Related]
8. Translational research in pancreatic cancer: KRAS and beyond.
Boeck S; Ormanns S; Haas M; Bächmann S; Laubender RP; Siveke JT; Jung A; Kirchner T; Heinemann V
Pancreas; 2014 Jan; 43(1):150-2. PubMed ID: 24326376
[No Abstract] [Full Text] [Related]
9. Long-term survivors of pancreatic adenocarcinoma show low rates of genetic alterations in KRAS, TP53 and SMAD4.
Masetti M; Acquaviva G; Visani M; Tallini G; Fornelli A; Ragazzi M; Vasuri F; Grifoni D; Di Giacomo S; Fiorino S; Lombardi R; Tuminati D; Ravaioli M; Fabbri C; Bacchi-Reggiani ML; Pession A; Jovine E; de Biase D
Cancer Biomark; 2018 Feb; 21(2):323-334. PubMed ID: 29103024
[TBL] [Abstract][Full Text] [Related]
10. Mutations in key driver genes of pancreatic cancer: molecularly targeted therapies and other clinical implications.
Hu HF; Ye Z; Qin Y; Xu XW; Yu XJ; Zhuo QF; Ji SR
Acta Pharmacol Sin; 2021 Nov; 42(11):1725-1741. PubMed ID: 33574569
[TBL] [Abstract][Full Text] [Related]
11. Pancreatic adenocarcinomas without KRAS, TP53, CDKN2A and SMAD4 mutations and CDKN2A/CDKN2B copy number alterations: a review of the genomic landscape to unveil therapeutic avenues.
Voutsadakis IA; Digklia A
Chin Clin Oncol; 2023 Feb; 12(1):2. PubMed ID: 36922358
[TBL] [Abstract][Full Text] [Related]
12. KRAS mutations in codon 12 or 13 are associated with worse prognosis in pancreatic ductal adenocarcinoma.
Sinn BV; Striefler JK; Rudl MA; Lehmann A; Bahra M; Denkert C; Sinn M; Stieler J; Klauschen F; Budczies J; Weichert W; Stenzinger A; Kamphues C; Dietel M; Riess H
Pancreas; 2014 May; 43(4):578-83. PubMed ID: 24681874
[TBL] [Abstract][Full Text] [Related]
13. Genomic sequencing of key genes in mouse pancreatic cancer cells.
Wang Y; Zhang Y; Yang J; Ni X; Liu S; Li Z; Hodges SE; Fisher WE; Brunicardi FC; Gibbs RA; Gingras MC; Li M
Curr Mol Med; 2012 Mar; 12(3):331-41. PubMed ID: 22208613
[TBL] [Abstract][Full Text] [Related]
14. Using whole genome amplification (WGA) of low-volume biopsies to assess the prognostic role of EGFR, KRAS, p53, and CMET mutations in advanced-stage non-small cell lung cancer (NSCLC).
Lim EH; Zhang SL; Li JL; Yap WS; Howe TC; Tan BP; Lee YS; Wong D; Khoo KL; Seto KY; Tan L; Agasthian T; Koong HN; Tam J; Tan C; Caleb M; Chang A; Ng A; Tan P
J Thorac Oncol; 2009 Jan; 4(1):12-21. PubMed ID: 19096301
[TBL] [Abstract][Full Text] [Related]
15. Endoscopic ultrasound-guided fine-needle aspirate-derived preclinical pancreatic cancer models reveal panitumumab sensitivity in KRAS wild-type tumors.
Berry W; Algar E; Kumar B; Desmond C; Swan M; Jenkins BJ; Croagh D
Int J Cancer; 2017 May; 140(10):2331-2343. PubMed ID: 28198009
[TBL] [Abstract][Full Text] [Related]
16. Autophagy, p53, and pancreatic cancer.
Iacobuzio-Donahue CA; Herman JM
N Engl J Med; 2014 Apr; 370(14):1352-3. PubMed ID: 24693896
[No Abstract] [Full Text] [Related]
17. DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer.
Iacobuzio-Donahue CA; Fu B; Yachida S; Luo M; Abe H; Henderson CM; Vilardell F; Wang Z; Keller JW; Banerjee P; Herman JM; Cameron JL; Yeo CJ; Halushka MK; Eshleman JR; Raben M; Klein AP; Hruban RH; Hidalgo M; Laheru D
J Clin Oncol; 2009 Apr; 27(11):1806-13. PubMed ID: 19273710
[TBL] [Abstract][Full Text] [Related]
18. Phenotype and genotype of pancreatic cancer cell lines.
Deer EL; González-Hernández J; Coursen JD; Shea JE; Ngatia J; Scaife CL; Firpo MA; Mulvihill SJ
Pancreas; 2010 May; 39(4):425-35. PubMed ID: 20418756
[TBL] [Abstract][Full Text] [Related]
19. Evolution and dynamics of pancreatic cancer progression.
Yachida S; Iacobuzio-Donahue CA
Oncogene; 2013 Nov; 32(45):5253-60. PubMed ID: 23416985
[TBL] [Abstract][Full Text] [Related]
20. Genetics and Biology of Pancreatic Ductal Adenocarcinoma.
Dunne RF; Hezel AF
Hematol Oncol Clin North Am; 2015 Aug; 29(4):595-608. PubMed ID: 26226899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]